Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)

Pharmacologic blockade of 5LO decreases Aβ peptides levels and deposition in the 3×Tg mice via the γ-secretase pathway. by Jin Chu (358006)

Nivalenol (NIV) decreases chondrocyte viability in a dose and duration-dependent manner. by Siyuan Li (178640)

CaA decreases the CSCs-like properties of malignant HaCaT cells. by Ye Yang (297214)

Galiellalactone decreases the proportion of ALDH+ prostate cancer cells in vitro and the ALDH1A1 expression in vivo. by Rebecka Hellsten (348459)

“…<p>A. DU145 and LNCaP-IL6 cells were treated with galiellalactone (5–50 µM) for 24 h and subjected to ALDEFLUOR® assay. …”

POm E-stimulation before whisker stimulus does not decrease cortical response magnitude and duration when PTX is applied in L1. by Carlos Castejon (2182382)

PTH decreased cell apoptosis in a Flt-3L expanded population. by Flavia Q. Pirih (360515)

POm E-stimulation before whisker stimulus does not decrease cortical response magnitude and duration when AGA is applied in L1. by Carlos Castejon (2182382)

Quercetin decreases proliferation (A) and induces apoptosis (B) in cultured PASMC from control rats. by Daniel Morales-Cano (668199)

Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. by Hyung-Ran Kim (532404)

Sildenafil decreases intestinal transit time in a DSS-recovery model of IBS. by Sarah K. Sharman (3966476)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

MSC treatment does not affect chronic LPS-induced decreased lung function. by P. Padmini S. J. Khedoe (4436458)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Prolonged Htr2b activation decreases ATP content and coupled mitochondrial respiration in MIN6. by Luis Rodrigo Cataldo (3701206)

High glucose-containing media decreases mitochondrial membrane potential and ATP levels of in mixed glia cultures. by Yung-Cheng Huang (3443450)

Subjects:

(Related to Fig 5B and 5C). Comparison of mean percentages of transfected cells with SGs calculated from three biological triplicates, showing the decrease in % as compared to wt N or the mutant N1a+N2b N. by Chiara Aloise (8374950)

Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

“…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”

CcnA mutation of Loop A decreases the interaction with the 5′ UTR of P2-<i>ctrA</i> mRNA and 5′ UTR of <i>gcrA</i> mRNA. by Wanassa Beroual (5314028)